Lawrence E. Roebel

401 total citations
14 papers, 305 citations indexed

About

Lawrence E. Roebel is a scholar working on Molecular Biology, Analytical Chemistry and Animal Science and Zoology. According to data from OpenAlex, Lawrence E. Roebel has authored 14 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Analytical Chemistry and 4 papers in Animal Science and Zoology. Recurrent topics in Lawrence E. Roebel's work include Receptor Mechanisms and Signaling (5 papers), Analytical Methods in Pharmaceuticals (5 papers) and Pharmacological Effects and Assays (4 papers). Lawrence E. Roebel is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Analytical Methods in Pharmaceuticals (5 papers) and Pharmacological Effects and Assays (4 papers). Lawrence E. Roebel collaborates with scholars based in United States and Canada. Lawrence E. Roebel's co-authors include Richard C. Dage, James K. Woodward, Hsien C. Cheng, Daniel Weiner, J. Martin Grisar, Takashi Kariya, Niall S. Doherty, Francis P. Miller, R L Cavanagh and J P Buyniski and has published in prestigious journals such as The American Journal of Cardiology, Clinical Pharmacology & Therapeutics and Journal of Pharmacy and Pharmacology.

In The Last Decade

Lawrence E. Roebel

13 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence E. Roebel United States	8	165	95	42	40	33	14	305
W. Bartsch United States	10	211 1.3×	114 1.2×	50 1.2×	49 1.2×	53 1.6×	31	441
N. W. Robie United States	8	168 1.0×	78 0.8×	27 0.6×	25 0.6×	27 0.8×	17	362
Allen W. Gomoll United States	12	257 1.6×	165 1.7×	60 1.4×	31 0.8×	45 1.4×	38	558
Brigitte Lecocq France	9	127 0.8×	63 0.7×	40 1.0×	31 0.8×	27 0.8×	15	325
Robert H. Seller United States	13	248 1.5×	117 1.2×	29 0.7×	27 0.7×	33 1.0×	34	579
Helen F. Oates Australia	10	179 1.1×	151 1.6×	33 0.8×	46 1.1×	57 1.7×	27	418
R. W. Sevy United States	11	145 0.9×	59 0.6×	22 0.5×	25 0.6×	50 1.5×	34	396
Brian N. C. Prichard United Kingdom	13	272 1.6×	64 0.7×	62 1.5×	35 0.9×	67 2.0×	18	542
Roy Jordan United Kingdom	9	109 0.7×	171 1.8×	74 1.8×	38 0.9×	106 3.2×	12	382
K. Haglund Sweden	13	147 0.9×	54 0.6×	57 1.4×	59 1.5×	29 0.9×	24	361

Countries citing papers authored by Lawrence E. Roebel

Since Specialization

Citations

This map shows the geographic impact of Lawrence E. Roebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence E. Roebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence E. Roebel more than expected).

Fields of papers citing papers by Lawrence E. Roebel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence E. Roebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence E. Roebel. The network helps show where Lawrence E. Roebel may publish in the future.

Co-authorship network of co-authors of Lawrence E. Roebel

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence E. Roebel. A scholar is included among the top collaborators of Lawrence E. Roebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence E. Roebel. Lawrence E. Roebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Marcinak, John, Prabhakar Viswanathan, Vipin Arora, et al.. (2011). Shift From Surrogate End Point to Outcome Trials: Implications for Cardiovascular Safety Assessment in Development Programs for Antidiabetic Drugs. Clinical Pharmacology & Therapeutics. 91(3). 514–520. 4 indexed citations

Doherty, Niall S., et al.. (1989). Pharmacological properties of MDL 19,301: A novel, nonsteroidal, anti‐inflammatory agent. Drug Development Research. 16(1). 31–44. 7 indexed citations

Roebel, Lawrence E., et al.. (1988). Dopamine and Norepinephrine Increase Venous Return by Stimulating α and β Adrenoceptors in the Dog. Journal of Cardiovascular Pharmacology. 11(6). 627–634. 6 indexed citations

Dudley, Mark W., Norbert L. Wiech, Francis P. Miller, et al.. (1988). Pharmacological effects of MDL 11,939: A selective, centrally acting antagonist of 5‐HT₂ receptors. Drug Development Research. 13(1). 29–43. 34 indexed citations

Dage, Richard C., et al.. (1987). Pharmacology of enoximone. The American Journal of Cardiology. 60(5). 10–14. 39 indexed citations

Dage, Richard C., Lawrence E. Roebel, John P. Gibson, Richard A. Okerholm, & Clyde N. Rolf. (1986). Enoximone. Cardiovascular Drug Reviews. 4(1). 63–79. 3 indexed citations

Roebel, Lawrence E., Richard A. Okerholm, Daniel Weiner, & James K. Woodward. (1985). Correlation between inotropic activity and drug plasma levels of a new cardiotonic agent, MDL 19205. Drug Development Research. 5(2). 123–128. 1 indexed citations

Roebel, Lawrence E., Richard C. Dage, Hsien C. Cheng, & James K. Woodward. (1984). In Vitro and In Vivo Assessment of the Cardiovascular Effects of the Cardiotonic Drug MDL 19205. Journal of Cardiovascular Pharmacology. 6(1). l50–l50. 25 indexed citations

Dage, Richard C., et al.. (1984). Cardiovascular Properties of a New Cardiotonic Agent, MDL 19205. Journal of Cardiovascular Pharmacology. 6(1). l43–l43. 11 indexed citations

10.

Dage, Richard C., et al.. (1984). Cardiovascular properties of a new cardiotonic agent, MDL 19205.. PubMed. 6(1). 35–42. 23 indexed citations

11.

Roebel, Lawrence E., et al.. (1983). Effect of MDL 17043, a new cardiotonic agent, on myocardial oxygen consumption. Journal of Pharmacy and Pharmacology. 35(4). 247–249. 7 indexed citations

12.

Roebel, Lawrence E., Richard C. Dage, Hsien C. Cheng, & James K. Woodward. (1982). Characterization of the Cardiovascular Activities of a New Cardiotonic Agent, MDL 17043 (1,3-Dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one). Journal of Cardiovascular Pharmacology. 4(5). 721–729. 54 indexed citations

13.

Dage, Richard C., et al.. (1982). Cardiovascular Properties of a New Cardiotonic Agent. Journal of Cardiovascular Pharmacology. 4(3). 500–508. 80 indexed citations

14.

Roebel, Lawrence E., R L Cavanagh, & J P Buyniski. (1979). Comparative gastrointestinal and biliary tract effects of morphine and butorphanol (Stadol).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 10(4). 225–38. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact